Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0KP0W
|
|||
| Drug Name |
Valproic Acid
|
|||
| Synonyms |
VALPROIC ACID; 2-Propylpentanoic acid; 2-Propylvaleric acid; Dipropylacetic acid; Depakine; Depakene; Valproate; Ergenyl; Di-n-propylacetic acid; Mylproin
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Investigative | [1] | |
| Therapeutic Class |
Antiviral Agents
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C8H16O2
|
|||
| Canonical SMILES |
CCCC(CCC)C(=O)O
|
|||
| InChI |
1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
|
|||
| InChIKey |
NIJJYAXOARWZEE-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 99-66-1
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:39867
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Immunopharmacological management of COVID-19: Potential therapeutic role of valproic acid. Med Hypotheses. 2020 May 27;143:109891. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.